explore -WSS

explore

author：knowledge 2025-09-29 18:17:32 - browse：4258

Joe Biden in 2016. -- first opinion coverage from STAT — President Joe Biden Elise Amendola/AP

WASHINGTON — The latest phase of President Biden’s Cancer Moonshot initiative leaves open a few questions on how Congress might move forward with the program.

Since its launch in 2016, the federally funded cancer moonshot program has spurred thousands of scientific publications, 49 clinical trials, and more than 30 patent filings, according to a new report from the Congressional Research Service, the nonpartisan research arm of Congress.

The next phase of the cancer moonshot, according to Biden and his administration, is meant to emphasize cancer screening, prevention, and equitable treatment. The updated plan also seeks to speed progress on treatments for rare and childhood cancers, and it calls for supporting patients, survivors, and caregivers. The Advanced Research Projects Agency for Health (ARPA-H), a new agency tasked with taking big risks on biomedical and health technology, is also committing $240 million to cancer-related research and investing in new data-sharing platforms and a nationwide network for clinical trials.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： AstraZeneca lung cancer study comes in below expectations

WSS

Skip the lead apron during X

Vertex cell therapy lets patients with type 1 diabetes stop insulin

CDC says it’s too soon to assess risk posed by Covid subvariant

Prescription digital therapeutics are key to pharma’s future

How the first Native Hawaiian psychiatrist helped diversify medicine

Former Pear Therapeutics executives start new VC firm

Wikipedia

explore

explore

Virginia high school admissions case could be legal follow

How Robert F. Kennedy Jr. distorted vaccine science

Duchenne breakthrough therapy leaves behind pioneering families

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Cancer drug shortages should be causing more outrage

DeSantis wants to import drugs. Biden’s FDA blasted his plan

At least 13 dead in Texas as scorching temps continue

Drug cartel violence flares in western Mexico after vigilante leader's killing

Bright Health sells Medicare Advantage business to Molina

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

hotspot

Dexcom's push to bring CGM to type 2 diabetes patients

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Vivek Ramaswamy made waves in the debate, much as in biotech

Vertex cell therapy lets patients with type 1 diabetes stop insulin

'Screen and refer' systems are hurting patients

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

hotspot

Wikipedia

leisure time

leisure time